Melodi Health Announces $10.75 Million in Series A Funding, First Enrollment in Pivotal Clinical Trial Katie Lew · August 29, 2024
August 29, 2024 Melodi Health Announces $10.75 Million in Series A Funding, First Enrollment in Pivotal Clinical TrialGround-breaking investigational product from Melodi Health is designed to reduce post-surgical infections
August 27, 2024 NeuraWorx Partners with Corundum Neuroscience to Initiate Clinical Feasibility Study, Develop Innovative Neurological Disease TreatmentEXCELSIOR, Minn. – Aug. 27, 2024 – PRLog — NeuraWorx Medical Technologies, Inc., a neurotechnology therapeutics company, announced
August 27, 2024 Biocoat Incorporated Secures New Patent for Non-PFAS Inner Diameter CoatingHorsham, PA, [August 27, 2024] – Biocoat Incorporated, a leader in the
NewsIn the Know: Healthcare News for May 6, 2024 Tyler MasonMay 3, 2024 In the Know: Healthcare News for May 6, 2024
NewsBackstory Insurance Introduces a New Era of Expertise and Innovation in Risk Management for the Medical Industry Tyler MasonMay 3, 2024 Backstory Insurance Introduces a New Era of Expertise and Innovation in Risk Management for the Medical Industry
Articles, ReportsMedical Alley 2023 Annual Report Katie LewMay 2, 2024 Medical Alley 2023 Annual Report
NewsMonteris Medical Announces Market Release of NeuroBlate NB3 FullFire 1.6mm Laser Probe, Smallest Commercially Available Laser Probe for Use in the Brain Tyler MasonMay 1, 2024 Monteris Medical Announces Market Release of NeuroBlate NB3 FullFire 1.6mm Laser Probe, Smallest Commercially Available Laser Probe for Use in the Brain